News
Q1 2025 Management View CEO Paul Stoffels highlighted the appointment of Henry Gosebruch as the CEO of SpinCo, marking ...
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...
Reports Q1 revenue EUR 75M vs. EUR 62.4M last year. “We are making progress toward the planned separation announced early this year, ...
Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...
Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
Biosciences announced the first patient has been dosed in its Phase 2 trial of MB-105, a first-in-class CD5-targeted CAR-T ...
Irish Whisper Walk will be held Saturday, April 26 in the Pinecliff Lake section of West Milford. The event raises funds for ...
C4 Therapeutics, Inc.’s CCCC share price has surged by 17.60%, which has investors questioning if this is right time to sell.
After almost two decades of serving Blue Springs as a police officer, the city is now giving back to Lt. Brandon Claxton as ...
The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.
American Idol winner and Blue Springs native David Cook will be back in town this weekend to support a police officer who’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results